 Stroke modification Parkinson disease Previous studies incidence ischemic stroke persons Parkinson disease epidemiologic neurochemical facets Parkinson disease benefit protection ischemic stroke case-control method lifetime history ischemic stroke patients Parkinson disease controls similar age range Analysis myocardial infarction marker atherosclerotic disease stroke risk factors cumulative incidence ischemic stroke patients Parkinson disease controls cumulative incidence myocardial infarction risk factors patients Parkinson disease tobacco controls decreased incidence ischemic stroke patients Parkinson disease severe atherosclerosis due incidence tobacco use view potential dopamine experimental ischemic tissue damage possibility dopamine deficiency central nervous system persons Parkinson disease additional specific protective benefit ischemic stroke study